Search Results 1221-1230 of 14539 for استخدام حبوب منع الحمل

  1. A Study To Evaluate The Effectiveness And Safety Of CC-93538 To Treat Adults And Adolescents With Eosinophilic Esophagitis - Mayo Clinic

    About this study. The purposes of this study are to assess the effectiveness of CC-93538 versus placebo in reducing dysphagia symptoms at 24 weeks, ...

  2. Effects of Aprepitant on Satiation, Gastric Volume, Gastric Accommodation and Gastric Emptying - Mayo Clinic

    Reprint Permissions. A single copy of these materials may be reprinted for noncommercial personal use only. "Mayo," "Mayo Clinic," "MayoClinic.org," "Mayo ...

  3. A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Effectiveness of AMG 397 in Subjects With Multiple Myeloma, NHL, and AML - Mayo Clinic

    Females with a positive pregnancy test or planning to become pregnant while ... Any use of this site constitutes your agreement to the Terms and ...

  4. Novel Combinations of CC-122, CC-223, CC-292, and Rituximab in Diffuse Large B-cell Lymphoma - Mayo Clinic

    Medical records research — uses historical ... Women who are pregnant or breast feeding. Adults ... Any use of this site constitutes your agreement ...

  5. A Open Label Study Of The Efficacy And Safety Of PD0332991 A Selective Inhibitor Of The Cyclin Dependent Kinases 4 And 6 In Patients With Recurrent Ovarian Cancer Demonstrating Rb-proficiency And Low P16 Expression - Mayo Clinic

    A single copy of these materials may be reprinted for noncommercial personal use only. "Mayo," "Mayo Clinic," "MayoClinic.org ...

  6. Endometrial Cancer - Mayo Clinic

    ... site for clinical follow-up. Exclusion Criteria: Patient receiving or who has received neoadjuvant chemotherapy; Pre-operative population pregnant not an option.

  7. Lenalidomide, Rituximab, and Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Diffuse Large Cell or Follicular B-Cell Lymphoma - Mayo Clinic

    Drugs used in chemotherapy, such as cyclophosphamide, doxorubicin ... Not pregnant or nursing; Negative pregnancy test; Fertile female patients must use ...

  8. Study To Evaluate R2R01 Plus Terlipressin Versus Terlipressin Alone In Patients With Hepatorenal Syndrome - Mayo Clinic

    Female patients as well as female partners of male patients must be willing to avoid pregnancy for the duration of the study (> 90 days). ... Ongoing use of ...

  9. Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis - Mayo Clinic

    ... prevent the post-thrombotic syndrome(PTS)in ... Pregnant (positive pregnancy test, women of childbearing potential must be tested). ... Any use of this ...

  10. A Study to Evaluate Intravenous Erenumab in Patients with Status Migrainosus - Mayo Clinic

    The purpose of this study is to investigate the use of erenumab 140mg IV in patients with status migrainosus. The specific aims of the study are to evaluate ...